![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Baskent University |
---|---|
Information provided by: | Baskent University |
ClinicalTrials.gov Identifier: | NCT00522158 |
We aimed to compare the effect of achieving an LDL-cholesterol <70 vs an LDL-cholesterol <100 mg/dL with simvastatin or atorvastatin on adrenal and testicular steroidogenesis, and cognition in diabetic patients.
Condition | Intervention | Phase |
---|---|---|
Type 2 Diabetes Mellitus Cardiovascular Disease LDL Cholesterol Cognition |
Drug: simvastatin Drug: atorvastatin |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Parallel Assignment |
Ages Eligible for Study: | 40 Years to 85 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | KA 05/75 |
Study First Received: | August 27, 2007 |
Last Updated: | August 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00522158 |
Health Authority: | Turkey: Ethics Committee |
Metabolic Diseases Simvastatin Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Atorvastatin |
Antimetabolites Molecular Mechanisms of Pharmacological Action Therapeutic Uses Antilipemic Agents Enzyme Inhibitors |
Cardiovascular Diseases Anticholesteremic Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Pharmacologic Actions |